Cargando…
Determinants of Antibody Response to a Third SARS-CoV-2 mRNA Vaccine Dose in Solid Organ Transplant Recipients: Results from the Prospective Cohort Study COVAC-Tx
Background: We studied factors related to humoral response in solid organ transplant (SOT) recipients following a three-dose regimen of an mRNA-based SARS-CoV-2 vaccine. Method: This was a prospective study of SOT recipients who received a third homologous dose of the BNT162b2 (Pfizer–BioNTech) vacc...
Autores principales: | Balsby, Daniel, Nilsson, Anna Christine, Möller, Sören, Lindvig, Susan Olaf, Davidsen, Jesper Rømhild, Abazi, Rozeta, Poulsen, Mikael Kjær, Holden, Inge Kristine, Justesen, Ulrik Stenz, Bistrup, Claus, Johansen, Isik Somuncu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031786/ https://www.ncbi.nlm.nih.gov/pubmed/35455314 http://dx.doi.org/10.3390/vaccines10040565 |
Ejemplares similares
-
Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls
por: Balsby, Daniel, et al.
Publicado: (2022) -
Immunogenicity of SARS‐CoV‐2 mRNA vaccine in solid organ transplant recipients
por: Holden, Inge K., et al.
Publicado: (2021) -
SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark
por: von Huth, Sebastian, et al.
Publicado: (2021) -
Thoracic ultrasonographic and clinical findings at 12-month follow-up of patients admitted with COVID-19
por: Falster, Casper, et al.
Publicado: (2023) -
Comparison of six commercially available SARS-CoV-2 antibody assays—Choice of assay depends on intended use
por: Nilsson, Anna Christine, et al.
Publicado: (2021)